Treasury stock

GOGL – Declaration of options

Retrieved on: 
Monday, March 15, 2021
Financial markets, Finance, Stock market, Financial economics, Options, Corporate finance, Equity securities, Exercise, Share, Treasury stock, Security, NASDAQ

The Board of Golden Ocean Group Limited (NASDAQ and OSE: GOGL) (Golden Ocean or the Company) announced an option holder has exercised options to acquire 25,000 shares in the Company in accordance with the terms previously disclosed.

Key Points: 
  • The Board of Golden Ocean Group Limited (NASDAQ and OSE: GOGL) (Golden Ocean or the Company) announced an option holder has exercised options to acquire 25,000 shares in the Company in accordance with the terms previously disclosed.
  • The option exercise will be settled in full with treasury shares held by the Company.
  • Following the delivery of the shares, Golden Ocean will hold a total of 820,000 treasury shares.
  • This information is subject to the disclosure requirements of section 5-12 of the Norwegian Securities Trading Act.

Santhera Completes Capital Increase for Financing Arrangements

Retrieved on: 
Wednesday, March 10, 2021
Branches of biology, Leber's hereditary optic neuropathy, Idebenone, Financial economics, Stock market, Finance, Optic neuropathy, Leber, Share, Treasury stock

Pratteln, Switzerland, March10, 2021 Santhera Pharmaceuticals (SIX: SANN) announces that it has issued 480,708 treasury shares.

Key Points: 
  • Pratteln, Switzerland, March10, 2021 Santhera Pharmaceuticals (SIX: SANN) announces that it has issued 480,708 treasury shares.
  • On March9, 2021, and as announced when calling the extraordinary general meeting of shareholders scheduled for March18, 2021, 480,708 shares were issued out of the existing authorized capital as treasury shares.
  • Santhera expects to use these shares for purposes of its financing arrangements.
  • Santhera out-licensed ex-North American rights to its first approved product, Raxone (idebenone), for the treatment of Leber's hereditary optic neuropathy (LHON) to Chiesi Group.

DGAP-News: AURELIUS Equity Opportunities SE & Co. KGaA: AURELIUS Equity Opportunities retires 1,000,000 treasury shares purchased under buyback programs

Retrieved on: 
Tuesday, March 9, 2021
Financial markets, Stock market, Balance sheet, Financial economics, Finance, Corporate finance, Share repurchase, Equity securities, Buyback, Treasury stock, Equity, Aurelius Group

DGAP-News: AURELIUS Equity Opportunities SE & Co. KGaA / Key word(s): Miscellaneous

Key Points: 
  • DGAP-News: AURELIUS Equity Opportunities SE & Co. KGaA / Key word(s): Miscellaneous
    AURELIUS Equity Opportunities SE & Co. KGaA: AURELIUS Equity Opportunities retires 1,000,000 treasury shares purchased under buyback programs
    The issuer is solely responsible for the content of this announcement.
  • Munich/Grnwald, March 9, 2021 - AURELIUS Equity Opportunities SE & Co. KGaA (ISIN DE000A0JK2A8) resolved today to retire 1,000,000 treasury shares that were purchased under share buyback programs.
  • After the shares are retired, the share capital of AURELIUS Equity Opportunities SE & Co. KGaA will still be EUR 31,680,000.00, divided into 29,769,944 bearer shares in the form of no-par-value shares.
  • AURELIUS Equity Opportunities currently has 26 portfolio companies located across Europe which employ around 13,000 people and generate annual revenues of approx.

EQS-News: Relief Increases Issued Share Capital with Creation of Treasury Shares

Retrieved on: 
Monday, March 8, 2021
Finance, Companies, Financial markets, Relief Therapeutics, Corporate finance, OTC Markets Group, Share, Treasury stock, RLF, UBS

The 125,000,000 new shares, to be issued out of the Company's authorized capital, are fully subscribed for by Relief Therapeutics International SA, its 100% wholly owned subsidiary, and will be listed on the SIX Swiss Exchange on or around March 11, 2021.

Key Points: 
  • The 125,000,000 new shares, to be issued out of the Company's authorized capital, are fully subscribed for by Relief Therapeutics International SA, its 100% wholly owned subsidiary, and will be listed on the SIX Swiss Exchange on or around March 11, 2021.
  • Execution of the transaction will provide Relief with treasury shares, offering greater financial flexibility to raise funds in an efficient manner and in line with its equity plans for the Company and its subsidiaries.
  • Relief holds a patent issued in the United States and various other countries covering potential formulations of RLF-100TM.
  • RELIEF THERAPEUTICS Holding AG is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbol RLFTF.

ArcelorMittal announces closing of its first share buyback program and commencement of a second program

Retrieved on: 
Thursday, March 4, 2021
Financial markets, Stock market, Financial economics, Finance, Share repurchase, Buyback, ArcelorMittal, Share, Security, Repurchase agreement, Stock, Treasury stock

ArcelorMittal today announces that it has completed the share buyback program announced on 15 February 2021 under the authorization given by the annual general meeting of shareholders of 13 June 2020 (the AGM Authorization).

Key Points: 
  • ArcelorMittal today announces that it has completed the share buyback program announced on 15 February 2021 under the authorization given by the annual general meeting of shareholders of 13 June 2020 (the AGM Authorization).
  • By market close on 3 March 2021, ArcelorMittal had repurchased 27,113,321 million shares for a total value of approximately 536,570,952.53 (equivalent to US$649,999,934.95) at an approximate average price per share of 19.79.
  • This share buyback program will be completed by 31 December 2021.
  • The shares acquired under the Program are intended:
    to meet ArcelorMittals obligations under debt obligations exchangeable into equity securities, and/or;
    to reduce its share capital.

Coinsilium Group Limited: Exercise of Warrants

Retrieved on: 
Tuesday, March 2, 2021
Corporate finance, Financial markets, Financial economics, Finance, Equity securities, Options, Warrant, Fundamental analysis, Stock market, IOV, Shares outstanding, Treasury stock

On 4 December 2020 the Company announced that IOV had subscribed for 11,000,000 new Coinsilium ordinary shares at a price of 3p per share, investing GBP330,000 in a private placement.

Key Points: 
  • On 4 December 2020 the Company announced that IOV had subscribed for 11,000,000 new Coinsilium ordinary shares at a price of 3p per share, investing GBP330,000 in a private placement.
  • Following the exercise of the warrants, IOV Labs shareholding in Coinsilium increases from 20,434,000 to 25,934,000 ordinary shares representing an interest of 16.85% of the Company's outstanding shares, excluding warrants and treasury shares.
  • Given the early exercise of the IOV warrants, approximately 21 months prior to expiry, the Company has agreed to award IOV with 5,500,000 replacement warrants exercisable at a price of 12p per share valid for two years from the date of this announcement.
  • The Directors of Coinsilium Group Limited take responsibility for this announcement.

Travis Perkins: Total Voting Rights

Retrieved on: 
Tuesday, March 2, 2021
Financial markets, Corporate finance, Financial economics, Finance, Stock market, Equity securities, Corporate law, Issued shares, Common stock, Share capital, Share, Treasury stock

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with DTR5.6.1R, the Company notifies the market of the following:
    As at the date of this announcement, the Company's issued share capital consists of 252,143,923 ordinary shares with a nominal value of 10 pence each ("Ordinary Shares"), with voting rights.
  • The Company does not hold any Ordinary Shares in Treasury.
  • Therefore, the total number of Ordinary Shares with voting rights is 252,143,923.

Fuller, Smith & Turner PLC: Treasury Stock

Retrieved on: 
Monday, March 1, 2021
Stock market, Financial economics, Finance, Corporate finance, Equity securities, Money, Balance sheet, Treasury stock, Share

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • The Company announces that, following the transfer of 1,063 'A' Ordinary shares from the Treasury Shares Account to participants exercising Share Options under the Company's Save as You Earn Share Option Scheme, the number of 'A' ordinary shares of 0.40 each in issue is 33,619,834 of which 1,273,146 (3.79%) are Treasury shares.

DGAP-News: BP p.l.c.: Total Voting Rights

Retrieved on: 
Friday, February 26, 2021
Financial markets, Corporate finance, Financial economics, Finance, Stock market, Equity securities, Corporate law, Balance sheet, Treasury stock, Issued shares, Dividend, Share

For further information, please contact [email protected] or visit www.rns.com .1, the issued share capital of BP p.l.c.

Key Points: 
  • For further information, please contact [email protected] or visit www.rns.com .1, the issued share capital of BP p.l.c.
  • The number of ordinary shares which have been bought back and are held in treasury by BP p.l.c.
  • These treasury shares are not taken into consideration in relation to the payment of dividends and voting at shareholder meetings.
  • The total number of voting rights in BP p.l.c.

Asetek A/S Announces Transactions Carried Out Under the Current Share Buyback Programme in Accordance With the "Safe Harbour Method"

Retrieved on: 
Tuesday, February 23, 2021
Concurrent computing, Computing, Distributed computing, Buyback, Share repurchase, Asetek, Data center, Treasury stock

With the transactions stated above, the Company owns a total of 1,148,710 shares as treasury shares, corresponding to 4.29% of the share capital.

Key Points: 
  • With the transactions stated above, the Company owns a total of 1,148,710 shares as treasury shares, corresponding to 4.29% of the share capital.
  • See the enclosure for information about the individual transactions made under the share buyback programme.
  • Asetek is the global leader in liquid cooling solutions for gaming and enthusiast PCs, data centers and servers.
  • Founded in 2000, Asetek is headquartered in Denmark and has operations in California, Texas, China and Taiwan.